We are excited to announce that BIOVERIC Pharmaceuticals will be attending BioLabs Investor Day on April 22, 2025 in Philadelphia! We are dedicated to developing new drug products for patients with unmet needs.
We are focused on addressing key treatment challenges faced by patients and the people who care for them.
Connect with our CEO Sandip Patel for potential collaboration opportunities. We look forward to meeting you and discussing how we can work together to make a difference in patient care.
BIOVERIC's programs are investigational product candidates. They have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency, and their safety and effectiveness have not been established.
NewerWe are selected for Nurture Program Cohort 3 at TiE NJOlderDr. Sripal Reddy Palavai Joins BIOVERIC Advisory Board
← All news